Skip to main content

OPPENHEIMER ASSET MANAGEMENT INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1269119 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed Apr 24, 2026
Position Value
$1,885,593
-$158,459 QoQ
Shares Held
14,313
-0.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $43,091,495 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (4.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
14,313 $1,885,593

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,885,593 14,313
2025-12-31 $2,044,052 14,412
2025-09-30 $2,159,041 15,380
2025-06-30 $2,035,547 16,195
2025-03-31 $1,547,624 13,993
2024-12-31 $1,903,356 13,944
2024-09-30 $1,585,195 13,758
2024-06-30 $2,085,147 15,146
2024-03-31 $1,851,022 13,421
2023-12-31 $2,039,248 15,477
2023-09-30 $1,792,012 15,929
2023-06-30 $1,338,397 14,193
2023-03-31 $2,653,987 26,220
2022-12-31 $3,155,126 26,416
2022-09-30 $3,212,744 30,249
2022-06-30 $3,284,391 33,693
2022-03-31 $3,244,968 34,613
2021-12-31 $2,251,381 26,434
2021-09-30 $2,761,822 28,796
2021-06-30 $2,767,974 28,442
2021-03-31 $2,700,436 27,768
2020-12-31 $2,418,867 25,236
2020-09-30 $2,488,139 25,875
2020-06-30 $1,186,572 9,726
2020-03-31 $773,843 8,941